Long-term efficacy and safety of drug-coated balloons versus drug-eluting stents for small coronary artery disease (BASKET-SMALL 2): 3-year follow-up of a randomised, non-inferiority trial - The Lancet
Drug-Coated Balloon for De Novo Coronary Artery Disease: JACC State-of-the-Art Review - ScienceDirect
PDF) Drug-coated balloons for small coronary artery disease in patients with chronic kidney disease: a pre-specified analysis of the BASKET-SMALL 2 trial
Drug-coated balloons for small coronary artery disease in patients with chronic kidney disease: a pre-specified analysis of the BASKET-SMALL 2 trial | SpringerLink
Sultania Cardiovascular Sciences - BASKET SMALL 2 Trial Among patients undergoing PCI in small arteries, the use of a drug-coated balloon was noninferior to a drug-eluting stent. The drug-coated balloon was noninferior
Long-term efficacy and safety of drug-coated balloons versus drug-eluting stents for small coronary artery disease (BASKET-SMALL 2): 3-year follow-up of a randomised, non-inferiority trial - The Lancet
Drug-coated balloons for small coronary artery disease (BASKET-SMALL 2): an open-label randomised non-inferiority trial - The Lancet
DCB Only Followed by Provisional Stenting: Insights from BASKET-SMALL 2 Trial | tctmd.com
Drug-Coated Balloons for Small Coronary Artery Disease: BASKET-SMALL 2 - ppt download
BASKET-SMALL 2 - Drug-Coated Balloons vs. Drug- Eluting Stents in Small Vessel Interventions
Drug Coated Balloons safer than Drug Eluting Stents for small vessel coronary artery disease, confirms a BASKET-SMALL 2 trial
Drug-Coated Balloon for Small Coronary Artery Disease in Patients With and Without High-Bleeding Risk in the BASKET-SMALL 2 Trial | Circulation: Cardiovascular Interventions
Drug-coated balloons for small coronary artery disease (BASKET-SMALL 2): an open-label randomised non-inferiority trial - The Lancet
Long-term efficacy and safety of drug-coated balloons versus drug-eluting stents for small coronary artery disease (BASKET-SMALL 2): 3-year follow-up of a randomised, non-inferiority trial - The Lancet
Drug-coated balloons for small coronary artery disease in patients with chronic kidney disease: a pre-specified analysis of the BASKET-SMALL 2 trial | SpringerLink
Drug-Coated Balloon for Small Coronary Artery Disease in Patients With and Without High-Bleeding Risk in the BASKET-SMALL 2 Trial | Circulation: Cardiovascular Interventions
Drug-Coated Balloon for Small Coronary Artery Disease in Patients With and Without High-Bleeding Risk in the BASKET-SMALL 2 Trial | Circulation: Cardiovascular Interventions
Impact of Diabetes on Outcome With Drug-Coated Balloons Versus Drug-Eluting Stents: The BASKET-SMALL 2 Trial | JACC: Cardiovascular Interventions
Drug-coated balloons for small coronary artery disease (BASKET-SMALL 2): an open-label randomised non-inferiority trial - The Lancet
BASKET-SMALL 2: Drug-Coated Balloon Fares Well Against DES for De Novo Small-Vessel Disease | tctmd.com
